Prevalence of insulin resistance in metabolic disorders: The Bruneck Study

Diabetes

Volumn 47, Issue 10, 1998, Pages 1643-1649

  Bonora, Enzo ^a,d   Kiechl, Stefan ^c   Willeit, Johann ^c   Oberhollenzer, Friederich ^b   Egger, Georg ^b   Targher, Giovanni ^a   Alberiche, Maria ^a   Bonadonna, Riccardo C ^a   Muggeo, Michele ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b BRUNECK HOSPITAL   (Italy)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; URIC ACID;

EID: 0031710787     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.10.1643     Document Type: Article

References (51)

1. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Järvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988
2. DeFronzo RA: The triumvirate β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
3. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. TV Engl J Med 317:350-357, 1987
4. McKane WR, Stevens AB, Woods R, Andrews WJ, Henry RW, Bell PM: The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism 12:1240-1245, 1990
5. Karhapaa P, Malkki M, Laakso M: Isolated low HDL cholesterol: an insulin resistance state. Diabetes 43:411-417, 1994
6. Vuorinen-Markkola H, Yld-Järvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78:25-29, 1994
7. Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkanen L, Karter AJ, Hamman R, Saad MF: Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 46:63-69, 1997
8. Lind L, Berne C, Lithell H: Prevalence of insulin resistance inessential hypertension. J Hypertens 13:1457-1462, 1995
9. DeFronzo RA, Tobin JD, Andres R: The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin. Ant J Physiol 237:E214-E223, 1979
10. Fulcher GR, Walker M, Alberti KGMM: The assessment of insulin action in vivo. In International Textbook of Diabetes Mellitus. Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, Eds. New York, Wiley, 1992, p. 513-530
11. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M: Estimates of in vivo insulin action in man: comparison of insulin tolerance tests and euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68:374-378, 1989
12. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, Sands RE, Pei D, Savage PJ, Bergman RN, for the Insulin Resistance Atherosclerosis Study: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
13. Saad MF, Steil GM, Kades WW, Ayad MF, Elsewafy WA, Boyadjian R, Jinagouda SD, Bergman RN: Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 46:1167-1171, 1997
14. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:703-706, 1989
15. Modan M, Halkin H, Almong S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
16. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E: Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-years follow-up. Diabetologia 34:356-361, 1991
17. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
18. Haffner SM, Valdez RA, Hazuda HH, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 41:715-722, 1992
19. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetoiogia 28:412-419, 1985
21. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374-381, 1996
22. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810-817, 1985
23. Bonora E, Del Prato S, Bonadonna R, Gulli G, Solini A, Shank M, Ghiatas A, Lancaster J, Kilcoyne R, Alyassin A, DeFronzo R: Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41:1151-1159, 1992
24. Hales CN, Randle PJ: Immunoassay of insulin with insulin-antibody precipitate. Biochem J 88:137-144, 1963
25. Kiechl S, Willeit S, Poewe S, Egger G, Oberhollenzer F, Muggeo M, Bonora E: Insulin sensitivity and regular alcohol consumption: large, prospective, cross-sectional population study (Bruneck Study). BMJ 313:1040-1044, 1996
26. Bonora E, Willeit J, Kiechl S, Oberhollenzer F, Egger G, Bonadonna R, Muggeo M: Relationship between insulin and carotid atherosclerosis in the general population: the Bruneck Study. Stroke 28:1147-1152, 1997
27. Bray GA: An approach to the classification and evaluation of obesity. In Obesity. Björntorp P, Brodoff BN, Eds. Philadelphia, Lippincott, 1992, p. 294-308
28. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP). JAMA 269:3015-3023, 1993
30. Consensus Conference: Treatment of hypertriglyceridemia. JAMA 251:1196-1201, 1984
31. Saggiani F, Pilati S, Targher G, Branzi P, Muggeo M, Bonora E: Serum uric acid and related factors in 500 hospitalized subjects. Metabolism 45:1557-1561, 1996
32. Subcommittee of WHO/ISH Mild Hypertension Liaison Committee: Summary of 1993 World Health Organisation International Society hypertension guidelines for the management of mild hypertension. BMJ 307:1541-1546, 1993
33. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1507, 1988
34. Rossetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 13:610-630, 1990
35. Lewis GF, Uffelman KD, Szeto LW, Steiner G: Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL ApoB production in normal weight and obese individuals. Diabetes 42:833-842, 1993
36. Garg A: Insulin resistance in the pathogenesis of dyslipidemia, Diabetes Care 19:387-389, 1996
37. Quinones A, Santoro D, Natali A, Sampietro T, Boni C, Masoni A, Buzzigoli G, Ferrannini E: Insulin sensitivity in familial hypercholesterolemia. Metabolism 42:1359-1364, 1993
38. Karhapee P, Voutilainen E, Kovanen PT, Laakso M: Insulin resistance in familial and nonfamilial hypercholesterolemia. Arterioscl Thromb Vase Biol 13:41-47, 1993
39. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, Zenti MG, Branzi P, Santi L, Muggeo M: Relationship of fasting insulin to cardiovascular risk factor is already present in young men: the Verona Young Men Atherosclerosis Risk Factor Study. Eur J Clin Invest 27:248-254, 1997
40. Facchini F, Chen YDI, Hollenbeck CB, Reaven GM: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA 266:3008-3011, 1991
41. Quinones Galvan A, Natali A, Baldi S, Ferrannini E: Effect of insulin on uric acid excretion in humans. Am J Physiol 268:E1-E5, 1995
42. Reaven GM: Banting Lecture 1987: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
43. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G, on behalf of the European Group for the Study of Insulin Resistance (EGIR): Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166-1173, 1997
44. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R, for the IRAS Investigators: Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817, 1996
45. Bonora E, Tessari R, Micciolo R, Zenere M, Targher G, Padovani R, Falezza G, Muggeo M: Intimal-medial thickness of the carotid artery in nondiabetic and non-insulin-dependent diabetic patients: relationship with insulin resistance. Diabetes Care 20:627-631, 1997
46. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K, Pedersen O: Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians: analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98:1195-1209, 1996
47. Beard JC, Bergman RN, Ward WK, Porte DP Jr: The insulin sensitivity index in nondiabetic man: correlation between clamp-derived and IVGTT-derived values. Diabetes 35:362-369, 1986
48. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800, 1987
49. Groop LC: Drug treatment of non-insulin-dependent diabetes mellitus. In Textbook of Diabetes. Pickup J, Williams G, Eds. Oxford, U.K., Blackwell Science, 1997, p. 38.1-38.18
50. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 31:355-360, 1988
51. Phillips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292, 1994